Shankar Ramaswamy, MD

Shankar Ramaswamy is the Co-Founder, Chairman and Chief Executive Officer of Kriya Therapeutics, a biopharmaceutical company developing and manufacturing one-time gene therapies aiming to treat prevalent chronic diseases. Dr. Ramaswamy is regarded as one of the leading innovators in the field of biotechnology, having been involved in the scaling of multiple high growth companies. Prior to Kriya, Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, which pioneered a novel subsidiary-based model to rapidly accelerate the development and commercialization of medicines. In his time at Roivant, Dr. Ramaswamy was part of the team responsible for identifying and evaluating potential pipeline candidates and launching its first public subsidiary company, Axovant Sciences. He led corporate development at Axovant where he played a critical role in the execution of the company’s initial public offering in 2015, raising over $360 million in what was at the time the largest biotech IPO in history.

Dr. Ramaswamy received his Medical Degree from Brown University and his undergraduate degree in Economics from Harvard University. He has been the recipient of multiple industry awards, having been named the Triangle Business Journal Life Sciences Awards CEO of the Year in 2022 and one of the 2023 Pharma Voice 100 Trailblazers shaping tomorrow’s pharma landscape.